APON(SZ:300753) Xin Lang Cai Jing·2025-09-09 04:18Group 1 - The core point of the news is the decline in the stock price of Aipeng Medical, which fell by 5.07% to 31.05 CNY per share, with a trading volume of 222 million CNY and a turnover rate of 7.96%, resulting in a total market capitalization of 3.914 billion CNY [1] - Aipeng Medical, established on October 30, 2001, and listed on December 13, 2018, specializes in the research, production, and sales of medical devices in the fields of pain management and nasal care [1] - The company's main business revenue composition includes pain management products at 59.73%, nasal and upper airway products at 29.40%, and other products at 10.87% [1] Group 2 - From the perspective of fund holdings, Beixin Ruifeng Fund has one fund heavily invested in Aipeng Medical, specifically the Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056), which held 120,000 shares, accounting for 4.43% of the fund's net value, ranking as the tenth largest holding [2] - The Beixin Ruifeng Health Life Theme Flexible Allocation Fund (001056) was established on March 27, 2015, with a latest scale of 89.3779 million CNY, and has achieved a year-to-date return of 38.97%, ranking 1228 out of 8179 in its category [2] - The fund has a one-year return of 76.4%, ranking 927 out of 7984, and a cumulative return since inception of 32.3% [2]